| Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 0 | 682 | 1,145 | 1,224 | 1,292 | 1,285 | 1,170 | 1,306 | 1,160 | 1,139 | 1,077 | 1,020 | 969 | 1,070 | 1,020 | 1,040 | 1,056 | 1,047 |
| Expenses | 0 | 580 | 863 | 1,027 | 1,074 | 1,153 | 1,025 | 1,151 | 1,007 | 1,043 | 959 | 902 | 871 | 983 | 915 | 921 | 919 | 905 |
| EBITDA | 0 | 102 | 281 | 197 | 219 | 132 | 145 | 156 | 153 | 96 | 119 | 118 | 98 | 87 | 105 | 119 | 137 | 142 |
| Operating Profit % | 0 % | 15 % | 24 % | 16 % | 16 % | 10 % | 12 % | 11 % | 13 % | 8 % | 10 % | 11 % | 9 % | 7 % | 9 % | 11 % | 12 % | 13 % |
| Depreciation | 0 | 22 | 32 | 31 | 30 | 31 | 31 | 31 | 30 | 30 | 32 | 34 | 34 | 36 | 39 | 40 | 40 | 39 |
| Interest | 0 | 7 | 13 | 7 | 5 | 6 | 4 | 5 | 7 | 6 | 12 | 13 | 15 | 14 | 14 | 15 | 12 | 14 |
| Profit Before Tax | 0 | 77 | 243 | 165 | 187 | 115 | 116 | 124 | 122 | 76 | 81 | 80 | 55 | 51 | 66 | 80 | 96 | 102 |
| Tax | 0 | 23 | 75 | 54 | 58 | 46 | 36 | 40 | 30 | 23 | 24 | 22 | 17 | 22 | 17 | 21 | 26 | 28 |
| Net Profit | 0 | 54 | 168 | 111 | 129 | 69 | 79 | 84 | 92 | 52 | 58 | 58 | 39 | 29 | 49 | 59 | 69 | 74 |
| EPS in ₹ | 0.00 | 5.20 | 10.58 | 6.97 | 8.12 | 4.31 | 4.99 | 5.31 | 5.75 | 3.29 | 3.63 | 3.64 | 2.44 | 1.85 | 3.08 | 3.73 | 4.39 | 4.69 |
Jubilant Ingrevia
823.00
+15.55
(1.93%)
Market Cap
13,108.84 Cr
EPS
15.89
PE Ratio
51.27
Dividend Yield
0.61 %
Industry
Chemicals52 Week High
885.00
52 Week Low
525.00
PB Ratio
4.40
Debt to Equity
0.13
Sector
Specialty Chemicals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
2,983.40 | #1 1,51,750.27 | 72.07 | 13,387.50 | 5.69 | #1 2,096 | 40.49 | 38.90 | |
3,195.00 | 94,707.73 | 75.14 | 14,825.80 | #1 12.13 | 1,251 | 24.61 | 52.51 | |
3,446.00 | 37,854.31 | 68.67 | 4,737.00 | -25.09 | 523 | 89.11 | 37.39 | |
1,988.50 | 27,121.76 | #1 38.43 | 8,281.93 | -3.26 | 724 | -20.24 | 49.43 | |
527.35 | 26,043.15 | 45.84 | 4,664.30 | 10.33 | 555 | 34.98 | 62.22 | |
5,018.30 | 24,877.55 | 85.60 | 2,393.10 | 0.37 | 289 | 34.94 | 61.74 | |
7,616.00 | 22,422.84 | 45.62 | 5,692.40 | -13.69 | 499 | #1 121.26 | 58.88 | |
5,045.00 | 21,837.61 | 47.23 | #1 15,246.30 | - | 462 | -83.27 | 44.66 | |
1,963.70 | 20,356.82 | 49.79 | 2,248.17 | -8.77 | 424 | 18.04 | 53.26 | |
5,438.80 | 16,675.35 | 39.65 | 2,269.15 | -28.91 | 409 | -15.27 | 67.45 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
-13.21 %
Net Income Growth
-40.52 %
Cash Flow Change
-7.02 %
ROE
-42.06 %
ROCE
-37.57 %
EBITDA Margin (Avg.)
-9.44 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 0 | 3,379 | 3,797 | 4,259 | 4,732 | 5,032 |
| Fixed Assets | 0 | 1,805 | 1,798 | 1,846 | 2,539 | 3,106 |
| Current Assets | 0 | 1,424 | 1,765 | 1,818 | 1,780 | 1,853 |
| Capital Work in Progress | 0 | 65 | 174 | 525 | 331 | 525 |
| Investments | 0 | 50 | 6 | 8 | 16 | 943 |
| Other Assets | 0 | 1,458 | 1,819 | 1,880 | 1,846 | 0 |
| Total Liabilities | 0 | 3,379 | 3,797 | 4,259 | 4,732 | 5,032 |
| Current Liabilities | 0 | 894 | 1,053 | 1,180 | 1,286 | 1,401 |
| Non Current Liabilities | 0 | 561 | 311 | 413 | 708 | 704 |
| Total Equity | -0 | 1,923 | 2,433 | 2,666 | 2,738 | 2,927 |
| Reserve & Surplus | -0 | 1,907 | 2,417 | 2,650 | 2,722 | 2,911 |
| Share Capital | 0 | 16 | 16 | 16 | 16 | 16 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 0 | 73 | -36 | 35 | 6 |
| Investing Activities | 0 | 33 | -71 | -469 | -568 |
| Operating Activities | 0 | 112 | 453 | 463 | 430 |
| Financing Activities | 0 | -72 | -418 | 42 | 144 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 50.68 % | 50.92 % | 50.92 % | 51.03 % | 51.10 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.35 % | 6.58 % | 6.55 % | 7.22 % | 6.89 % | 7.12 % |
| DIIs | 0.83 % | 0.96 % | 0.32 % | 0.14 % | 0.15 % | 0.17 % | 1.38 % | 4.90 % | 5.98 % | 6.73 % | 8.21 % | 11.18 % | 13.61 % | 14.09 % | 15.47 % | 15.99 % | 15.92 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 16.76 % | 21.30 % | 27.18 % | 26.23 % | 27.31 % | 27.61 % | 26.71 % | 25.75 % | 25.72 % | 26.13 % | 24.11 % | 22.74 % | 20.63 % | 20.57 % | 19.47 % | 19.17 % | 19.13 % |
| Others | 31.74 % | 26.82 % | 21.58 % | 22.60 % | 21.43 % | 20.75 % | 20.44 % | 17.87 % | 16.83 % | 15.66 % | 16.20 % | 8.26 % | 7.71 % | 7.32 % | 6.36 % | 6.47 % | 6.36 % |
| No of Share Holders | 60,038 | 95,235 | 1,49,939 | 1,81,847 | 1,91,477 | 1,93,858 | 1,95,704 | 1,86,895 | 1,85,062 | 1,86,294 | 1,73,533 | 1,62,202 | 1,50,388 | 1,42,736 | 1,25,367 | 1,24,830 | 1,20,406 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 | 5 | 5 | 5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 1.39 | 1.1 | 0.77 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Jul 2025 |  Dividend | ₹ 2.50 /share | 25 Jul 2025 | 718.00 | 807.45 |
| 13 May 2025 |  Quarterly Result Announcement | NA | 13 May 2025 | 696.10 | 718.00 |
| 03 Feb 2025 | Dividend | ₹ 2.50 /share | 03 Feb 2025 | 659.30 | 697.65 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 711.10 | 659.30 |
| 22 Oct 2024 | Quarterly Result Announcement | NA | 22 Oct 2024 | 732.20 | 731.40 |
| 30 Aug 2024 |  Annual General Meeting | NA | 30 Aug 2024 | 610.10 | 642.85 |
| 02 Aug 2024 | Dividend | ₹ 2.50 /share | 02 Aug 2024 | 519.65 | 612.55 |
| 09 Feb 2024 | Dividend | ₹ 2.50 /share | 09 Feb 2024 | 460.65 | 436.55 |
| 10 Aug 2023 | Dividend | ₹ 2.50 /share | 10 Aug 2023 | 422.00 | 433.05 |
| 10 Feb 2023 | Dividend | ₹ 2.50 /share | 10 Feb 2023 | 472.90 | 472.65 |
| 24 Aug 2022 | Dividend | ₹ 2.50 /share | 23 Aug 2022 | 464.15 | 476.15 |
| 11 Feb 2022 | Dividend | ₹ 2.50 /share | 10 Feb 2022 | 572.25 | 567.85 |
| 06 Aug 2021 | Dividend | ₹ 0.35 /share | 05 Aug 2021 | 571.85 | 610.15 |
| 01 Feb 2021 |  Change Of Name | NA | 01 Feb 2021 | 0.00 | 0.00 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
3 days ago
3 days agoClosure of Trading WindowJun 26, 2025
Jun 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 16, 2025
Jun 16, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 13, 2025
Jun 13, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedJun 06, 2025
Jun 06, 2025Intimation Of Repayment Of Commercial Paper (CP)Jun 06, 2025
Jun 06, 2025Intimation Of Record Date For Maturity Of Commercial PapersJun 06, 2025
Jun 06, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesJun 06, 2025
Jun 06, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Response To BSE In Reference To Mail Received On May 29 2025May 29, 2025
May 29, 2025Clarification sought from Jubilant Ingrevia LtdMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-RetirementMay 24, 2025
May 24, 2025Intimation Of Record Date For Maturity Of Commercial Papers
May 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 18, 2025
May 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 13, 2025
May 13, 2025Intimation Of Record Date - Friday July 25 2025May 13, 2025
May 13, 2025Corporate Action-Board approves DividendMay 13, 2025
May 13, 2025Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2025May 13, 2025
May 13, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On May 13 2025May 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 28, 2025
Apr 28, 2025Board Meeting Intimation for 1. Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025; And
2. Recommendation Of Final Dividend For The Financial Year Ended March 31 2025 Ifany.Apr 28, 2025
Apr 28, 2025Updates On AcquisitionApr 25, 2025
Apr 25, 2025Update On Material Development About The Disclosure Made On February 25 2025Apr 20, 2025
Apr 20, 2025Commercial Paper Proceeds Utilisation Certificate For The Quarter Ended March 31 2025Apr 14, 2025
Apr 14, 2025Intimation Of Record Date For Maturity Of Commercial PaperApr 08, 2025
Apr 08, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesApr 08, 2025
Apr 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 31, 2025
Mar 31, 2025Addendum To Trust Deed Of Jubilant Ingrevia Employees Welfare TrustMar 27, 2025
Mar 27, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedMar 27, 2025
Mar 27, 2025Intimation of Repayment of Commercial Paper (CP)Mar 27, 2025
Mar 27, 2025Closure of Trading WindowMar 25, 2025
Mar 25, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 12, 2025
Mar 12, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMar 06, 2025
Mar 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 28, 2025
Feb 28, 2025Intimation of Repayment of Commercial Paper (CP)Feb 25, 2025
Feb 25, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024
Feb 25, 2025
Feb 25, 2025Rumour verification - Regulation 30(11)Feb 25, 2025
Feb 25, 2025Intimation Of Redemption Of Commercial PaperFeb 24, 2025
Feb 24, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As Amended
Feb 24, 2025
Feb 24, 2025Disclosure Of Material Event Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Feb 22, 2025
Feb 22, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 03, 2025
Feb 03, 2025Technical Indicators
RSI(14)
Neutral 63.73
ATR(14)
Volatile 29.16
STOCH(9,6)
Overbought 85.25
STOCH RSI(14)
Neutral 71.70
MACD(12,26)
Bullish 3.20
ADX(14)
Strong Trend 37.42
UO(9)
Bearish 58.28
ROC(12)
Uptrend And Accelerating 5.12
WillR(14)
Overbought -17.38
Mutual Fund Holdings
Kotak Small Cap Fund Direct-Growth 
Axis Small Cap Fund Direct-Growth 
HDFC Manufacturing Fund Direct - Growth 
DSP Small Cap Direct Plan-Growth 
Bandhan Innovation Fund Direct-Growth 
Motilal Oswal Multi Cap Fund Direct - Growth 
ICICI Prudential Regular Savings Fund Direct-Growth 
ITI ELSS Tax Saver Fund Direct - Growth 
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth 
SBI Nifty Smallcap 250 Index Fund Direct - Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth About Jubilant Ingrevia
Jubilant Ingrevia Limited is a global integrated Life Science products and Innovative Solutions provider. Incorporated in 2019, the company serves Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers. It operates through three core segments: Speciality Chemicals, Nutrition and Health Solutions, and Life Science Chemicals. The company manufactures and supplies speciality intermediates, nutrition & health solutions, and life science chemicals through five facilities in India. Jubilant Ingrevia is the global largest producer of Niacinamide and among the top two manufacturers of Vitamin B3 globally. It serves over 1400 customers in more than 60 countries and offers custom research and manufacturing services. The company is part of the Jubilant Bhartia Group and became a separate entity following a demerger from Jubilant Pharmova Limited in 2021.
Chairperson NameShyam S Bhartia
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
